SEC Info - Tautachrome Inc. - ‘10-Q’ for 6/30/22

Page	(sequential)		(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Consolidated Financial Statements Controls and Procedures Defaults Upon Senior Securities Exhibits Financial Information Legal Proceedings Management's Discussion And Analysis Of Financial Condition And Results Of Operations Mine Safety Disclosures Other Information Part I -- Financial Information Part Ii -- Other Information Quantitive And Qualitative Disclosures About Market Risk Signatures Table of Contents Unregistered Sale of Equity Securities
1	1st Page – Filing Submission
"	Table of Contents
"	Part I -- Financial Information
"	Item 2 -- Management's Discussion And Analysis Of Financial Condition And Results Of Operations
"	Item 3 -- Quantitive And Qualitative Disclosures About Market Risk
"	Part Ii -- Other Information
"	Item 1 -- Legal Proceedings
"	Item 2 -- Unregistered Sale of Equity Securities
"	Item 4 -- Mine Safety Disclosures
"	Signatures

i 0001389067 i false i --12-31 i Q2 i 2022 i 0.00001 i 6400000000.0 i 5866608915 i 5962823071 i 0.00001 i 0.0001 i 40000 i 290400 i 40000 i 40000 i 290400 i 40000 i 290400 i 290400 i 1479530 i 132800800013890672022-01-012022-06-300001389067us-gaap:SubsequentEventMember2022-07-012022-07-050001389067us-gaap:SubsequentEventMember2022-07-050001389067ttcm:ConvertiblePromissoryNotesMember2022-01-012022-06-300001389067ttcm:ShortTermConvertibleNotesPayableThirdPartyNetMember2022-06-300001389067srt:MaximumMemberttcm:ConvertibleNoteDerivativesMember2022-01-012022-06-300001389067srt:MinimumMemberttcm:ConvertibleNoteDerivativesMember2022-01-012022-06-300001389067ttcm:ConvertibleNoteDerivativesMember2022-01-012022-06-300001389067ttcm:ConvertibleNoteDerivativesMember2022-06-300001389067us-gaap:LoansMember2022-06-300001389067ttcm:PromissoryNotesMember2022-06-300001389067ttcm:PromissoryNotesMember2022-01-012022-06-300001389067ttcm:ShortTermConvertibleNotesPayableRelatedPartyMemberttcm:DavidLaMountainMember2022-06-300001389067ttcm:ShortTermConvertibleNotesPayableRelatedPartyMember2022-06-300001389067ttcm:AustralianInvestorsMember2022-06-3000013890672022-03-3100013890672021-10-050001389067us-gaap:SeriesDPreferredStockMember2016-10-310001389067ttcm:StocksPayableMember2022-01-012022-06-300001389067ttcm:ConvertibleNotesPayableOneMember2022-01-012022-06-300001389067us-gaap:SeriesDPreferredStockMember2016-10-012016-10-310001389067ttcm:LongTermConvertibleNotesPayableMemberttcm:ArknetMember2022-06-300001389067ttcm:OfficersAndDirectorsMemberus-gaap:ConvertibleNotesPayableMember2022-06-300001389067ttcm:MichaelNugentMember2022-01-012022-06-300001389067us-gaap:LoansMemberttcm:DavidLaMountainMember2022-06-300001389067us-gaap:LoansMemberttcm:MichaelNugentMember2022-06-300001389067ttcm:NugentFamilyMember2022-06-300001389067ttcm:AccruedLicenseFeesMemberttcm:ArknetMember2022-06-300001389067ttcm:DrJonLeonardMember2022-06-300001389067ttcm:ConvertibleNotesPayableRelatedPartyMember2022-01-012022-06-300001389067ttcm:ConvertibleNotesPayableRelatedPartyMember2022-06-3000013890672022-07-012022-07-0500013890672021-06-300001389067us-gaap:RetainedEarningsMember2022-06-300001389067us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001389067ttcm:StockPayableMember2022-06-300001389067us-gaap:AdditionalPaidInCapitalMember2022-06-300001389067ttcm:PreferredStockSeriesFMember2022-06-300001389067ttcm:PreferredStockSeriesEMember2022-06-300001389067us-gaap:CommonStockMember2022-06-300001389067us-gaap:RetainedEarningsMember2022-01-012022-06-300001389067us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-06-300001389067ttcm:StockPayableMember2022-01-012022-06-300001389067us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001389067ttcm:PreferredStockSeriesFMember2022-01-012022-06-300001389067ttcm:PreferredStockSeriesEMember2022-01-012022-06-300001389067ttcm:PreferredStockSeriesDMember2022-01-012022-06-300001389067us-gaap:CommonStockMember2022-01-012022-06-300001389067us-gaap:RetainedEarningsMember2021-12-310001389067us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001389067ttcm:StockPayableMember2021-12-310001389067us-gaap:AdditionalPaidInCapitalMember2021-12-310001389067ttcm:PreferredStockSeriesFMember2021-12-310001389067ttcm:PreferredStockSeriesEMember2021-12-310001389067ttcm:PreferredStockSeriesDMember2021-12-310001389067us-gaap:CommonStockMember2021-12-3100013890672021-01-012021-12-310001389067us-gaap:RetainedEarningsMember2021-01-012021-12-310001389067us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-12-310001389067ttcm:StockPayableMember2021-01-012021-12-310001389067us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001389067ttcm:PreferredStockSeriesFMember2021-01-012021-12-310001389067ttcm:PreferredStockSeriesEMember2021-01-012021-12-310001389067ttcm:PreferredStockSeriesDMember2021-01-012021-12-310001389067us-gaap:CommonStockMember2021-01-012021-12-3100013890672020-12-310001389067us-gaap:RetainedEarningsMember2020-12-310001389067us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001389067ttcm:StockPayableMember2020-12-310001389067us-gaap:AdditionalPaidInCapitalMember2020-12-310001389067ttcm:PreferredStockSeriesFMember2020-12-310001389067ttcm:PreferredStockSeriesEMember2020-12-310001389067ttcm:PreferredStockSeriesDMember2020-12-310001389067us-gaap:CommonStockMember2020-12-3100013890672021-04-012021-06-3000013890672022-04-012022-06-3000013890672021-01-012021-06-300001389067ttcm:SeriesFConvertiblePreferredStockMember2021-12-310001389067ttcm:SeriesFConvertiblePreferredStockMember2022-06-300001389067ttcm:SeriesEConvertiblePreferredStockMember2021-12-310001389067ttcm:SeriesEConvertiblePreferredStockMember2022-06-3000013890672021-12-3100013890672022-06-3000013890672022-08-01iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. i Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). i Yes ☒ No

Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in rule 12b-2 of the Exchange Act). Yes i ☐ No ☒

The accompanying notes are an integral part of these consolidated financial statements.

Long-term Convertible Notes Payable, Related Party consists of $ i 40,000 due to Arknet with unamortized discounts of $ i 13,254.

i According to our agreement with Mr. Nugent, we accrue interest on all unpaid amounts at 5%. Principal and interest are callable at any time. If principal and interest are called and not repaid, the loan is considered in default after which interest is accrued at 10%.

On May 5, 2013 (and on August 8, 2013 with an enlargement amendment) the Company entered into a no interest demand-loan agreement with our current Chairman, Jon N. Leonard under which the Company may borrow such money from Dr. Leonard as Dr. Leonard in his sole discretion is willing to loan.

The terms of the note provide that at the Company’s option, the Company may make repayments in stock, at a fixed share price of $ i 1.00 per share. Also, because this loan is a no-interest loan, an imputed interest expense of $ i 8 was recorded as additional paid-in capital for the six months ended June 30, 2022. The Company evaluated Dr. Leonard’s note for the existence of a beneficial conversion feature and determined that none existed.

In October, 2016 we issued i 13,795,104 shares of Series D preferred stock to our (then) directors in exchange for i 1,379,510,380 shares of common stock. This series of preferred stock was subject to two separate rights to convert to common stock. The first could be elected by the shareholder if the stock sold for greater than $3 per share. The second was automatic and would not be trigger until October 5, 2021. On that date, the original i 1,379,510,380 common shares were issued retiring the Series D preferred stock. There was no gain or loss on the conversion because the value of the common shares issued equaled the value of the Series D Preferred shares.

Certain of our promissory notes bear no nominal interest. We therefore imputed interest expense and increased Additional Paid in Capital. For the six months ended June 30, 2022, we imputed $ i 4,722 of such interest. For the same period in 2021, we imputed $ i 2,830.

At June 30,2022, we owed AU$22,000 (US$ i 15,189) to three Australian investors on promissory notes which contain no conversion privileges.

In addition, during the six months ended June 30, 2022 we issued a promissory note in the amount of $ i 54,000, receiving proceeds of $ i 50,000 and incurring an original issue discount of $ i 4,000. On this note, we also issued i 1,600,000 common shares as an enticement for this loan which we valued at $ i 3,200, also recorded as a debt discount (for a total initial discount of $ i 7,200). During the six months ended June 30, 2022, we amortized $ i 2,185 of this discount.

The above-referenced convertible promissory notes were analyzed in accordance with EITF 07–05 and ASC 815. EITF 07–5, which is effective for fiscal years beginning after December 15, 2009, and interim periods within those fiscal years. The objective of EITF 07–5 is to provide guidance for determining whether an equity–linked financial instrument is indexed to an entity’s own stock. This determination is needed for a scope exception under Paragraph 11(a) of ASC 815 which would enable a derivative instrument to be accounted for under the accrual method. The classification of a non–derivative instrument that falls within the scope of EITF 00–19 “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock” also hinges on whether the instrument is indexed to an entity’s own stock. A non–derivative instrument that is not indexed to an entity’s own stock cannot be classified as equity and must be accounted for as a liability. The EITF reached a consensus that would establish a two–step approach in determining whether an instrument or embedded feature is indexed to an entity’s own stock. First, the instrument's contingent exercise provisions, if any, must be evaluated, followed by an evaluation of the instrument's settlement provisions.

Derivative financial instruments should be recorded as liabilities in the consolidated balance sheet and measured at fair value. For purposes of this engagement and report, we utilized fair value as the basis for formulating our opinion which has been defined by the Financial Accounting Standards Board (“FASB”) as “the amount for which an asset (or liability) could be exchanged in a current transaction between knowledgeable, unrelated willing parties when neither party is acting under compulsion”. The FASB has provided guidance that its definition of fair value is consistent with the definition of fair market value in IRS Rev. Rule 59–60.

The Company issued certain fixed-rate convertible Subscription Notes from 2015 through June 30, 2022 in the United States and Australia These convertible notes have become tainted (“The Tainted Notes”) as a result of the issuance of convertible promissory notes issued in the United States since there is a possibility (however remote) that the Company would not have enough shares in the Treasury to satisfy all possible conversions.

The Convertible Note derivatives were valued as of issuance; conversion; redemption/settlement; and each quarterly period from March 31, 2018 through June 30, 2022. The following assumptions were used for the valuation of the derivative liability related to the Notes:

We recorded the initial derivative as both a derivative liability and a debt discount (or initial reduction in carrying value of the debt). We then amortized the debt discounts using the Effective Interest Method which recognizes the cost of borrowing at a constant interest rate throughout the contractual term of the obligation. The effective interest rate on the only convertible instrument issued during the six months ended June 30, 2022 range was i 112%.

At each reporting date, we determine the fair market value for each derivative associated with each of the above instruments.

Item 2- Management’s Discussion And Analysis Of Financial Condition And Results Of Operations

This report contains “forward-looking statements”. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including: any projections of earnings, revenues or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new products, services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. “Forward-looking statements” may include the words “may,” “estimate,” “intend,” “continue,” “believe,” “expect,” “plan” or “anticipate” and other similar words.

Although we believe that the expectations reflected in our “forward-looking statements” are reasonable, actual results could differ materially from those projected or assumed. Our future financial condition and results of operations, as well as any “forward-looking statements”, are subject to change and to inherent risks and uncertainties, such as those disclosed in this report. In light of the significant uncertainties inherent in the “forward-looking statements” included in this report, the inclusion of such information should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved. Except for its ongoing obligation to disclose material information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any “forward-looking statement”. Accordingly, the reader should not rely on “forward-looking statements”, because they are subject to known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those contemplated by the “forward-looking statements”.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our unaudited financial statements, including the notes to those financial statements, included elsewhere in this report.

We are an early stage internet applications company, engaged in advanced technology and business development in the internet applications space. We have incurred general and administrative costs, marketing expenses and research and development costs since we commenced our current operations in May 2015, against minimal revenue.

The continuing operations of the Company are dependent upon our ability to raise adequate financing and to commence profitable operations in the future. The Company may raise additional capital through the sale of its equity securities, through an offering of debt securities, or through loans from related parties. We believe that actions presently being taken to obtain additional funding may provide the opportunity for the Company to continue as a going concern. There is no guarantee, however, that the Company will be successful in achieving these objectives.

General and administrative expenses went from $2,456,469 in 2021 to $393,851 in the current year for a decrease of $2,062,618. The vast majority of the change was 198,000,000 shares of stock issued in June, 2021 for advertisements. This did not occur in the current year.

Depreciation expense did not change from last year to this since we depreciate our only asset using the straight line method which causes depreciation expense to be the same from period to period.

Research and development expenses fell from $430,109 last year to $178,377 in the current year due to a decrease in development activities.

Interest expense fell from $659,052 in 2021 to $437,094 in 2022 ( decrease of $221,958), mostly because there were several large early payoffs of debt (in the form of conversion to common stock) occurring in the previous year requiring the full amortization of existing discount balances. Fewer such early payoffs occurred in the current year.

The change in value of our derivative liability resulted in a loss of $2,262,282 in 2021 versus a gain of $597,073 in 2022. See Note 6 to the financial statements for a calculation of these values.

During the current year we had foreign exchange gain of $44,999 versus a gain of $28,320 in the previous year, all of which are caused by fluctuations in the exchange rate differences between the U.S. and Australian dollars.

Our net comprehensive losses of $374,461 in the current year versus $5,937,638 in the previous year are a result of the above items.

General and administrative expenses went from $2,302,093 in 2021 to $185,471 in the current year for a decrease of $2,116,622. The vast majority of the change was 198,000,000 shares of stock issued in June, 2021 for advertisements. This did not occur in the current year.

We had bad debt expense of $150,760 in 2021 related to a loan we made which was ultimately not repaid. We had no such occurrence in the current year.

Depreciation expense did not change from last year to this since we depreciate our only asset using the straight line method which causes depreciation expense to be the same from period to period.

Research and development expenses fell from $229,334 last year to $91,495 in the current year due to a decrease in development activities.

Interest expense fell from $235,282 in 2021 to $211,734 in 2022 ( decrease of $23,548), mostly because there were several large early payoffs of debt (in the form of conversion to common stock) occurring in the previous year requiring the full amortization of existing discount balances. Fewer such early payoffs occurred in the current year.

The value of our derivative liability resulted in a loss of $358,835 in 2021 versus a gain of $564,639 in 2022. See Note 6 to the financial statements for a calculation of these values.

During the current year we had foreign exchange gain of $73,165 versus a gain of $16,941 in the previous year, all of which are caused by fluctuations in the exchange rate differences between the U.S. and Australian dollars.

Our net comprehensive gain and losses of a $145,485 in the current year versus $3,263,123 in the previous year are a result of the above items.

Our financial statements have been prepared on a going concern basis that contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.

At June 30, 2022, the Company had $123 in current assets and current liabilities totaling $4,765,801. We are currently seeking financing to attain our business goals, but there is no guarantee that we will obtain such financing or, upon obtaining it, that we will be able to invest in productive assets that will result in positive cash flows from operations.

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying financial statements, we had negative cash flows from operations, recurring losses, and negative working capital at June 30, 2022. These conditions raise substantial doubt as to our ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern. Management intends to finance these deficits by making additional shareholder notes and seeking additional outside financing through either debt or sales of its common stock.

Our immediate term plans for operations is discussed extensively in Item 7 – Management’s Discussion and Analysis or Plan of Operation included in our Form 10-K as of December 31, 2021, filed with the Securities and Exchange Commission on March 24, 2021 and is herein incorporated by reference.

A smaller reporting company is not required to provide the information required by this item.

We maintain "disclosure controls and procedures" as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934. In designing and evaluating our disclosure controls and procedures, our management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Based upon the evaluation of our officers and directors of our disclosure controls and procedures as of June 30, 2022, the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"), our Chief Executive Officer has concluded that as of the Evaluation Date that our disclosure controls and procedures were not effective such that the information relating to our company, required to be disclosed in our Securities and Exchange Commission reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure. Our management concluded that our disclosure controls and procedures were not effective as a result of material weaknesses in our internal control over financial reporting. We are a small organization with only a few employees. Under these circumstances it is impossible to completely segregate duties. We do not expect our internal controls to be effective until such time as we are able to begin full operations and even then, there are no assurances that our disclosure controls will be adequate in future periods.

There were no changes in our internal control over financial reporting that occurred during the three months ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

We may be involved from time to time in ordinary litigation, negotiation and settlement matters that will not have a material effect on our operations or finances. We are not aware of any pending or threatened litigation against us or our officers and directors in their capacity as such that could have a material impact on our operations or finances.

A portion of the securities were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), by reason of the exemption from registration afforded by the provisions of Section 4(a)(2) thereof, and Rule 506(b) of Regulation D promulgated thereunder, as a transaction by an issuer not involving any public offering. The investors did not enter into any of the transactions with the Company as a result of or subsequent to any advertisement, article, notice, or other communication published in any newspaper, magazine, or similar media or broadcast on television or radio, or presented at any seminar or meeting. Each investor was also afforded the opportunity to ask questions of management and to receive answers concerning the terms and conditions of the transaction. No selling commissions were paid in connection with these transactions.

A portion of the securities were issued without registration under the Securities Act, by reason of the exemption from registration afforded by Rule 903 of Regulation S promulgated thereunder. In determining that the issuance of certain of such securities qualified for exemption in reliance on Regulation S, the Company relied on the following facts: each recipient represented that it is not a “U.S. Person” within the meaning of Regulation S under the Securities Act and that he, she or it would not sell the shares in the U.S. for a period of at least one year after purchase.

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

i Delaware		i 84-2340972
(State or other Jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Title of Each Class	Trading Symbols	Name of Exchange on Which Registered
Not applicable	Not applicable	Not applicable

Large accelerated filer	☐	Accelerated filer	☐
i Non-accelerated Filer	☐	Smaller reporting company	i ☒
Emerging growth company	i ☐

	6/30/2022			12/31/2021
	(Unaudited)
ASSETS
Current assets:
Cash	$	i 123		$	i 119,466
Total current assets		i 123			i 119,466

Non-current assets:
Property, plant and equipment, net		i 18,102			i 25,344
TOTAL ASSETS	$	i 18,225		$	i 144,810

LIABILITIES
Accounts payable and accrued expenses	$	i 939,530		$	i 813,024
Accounts payable - related party		i 856,181			i 706,476
Loans from related parties		i 102,713			i 103,640
Convertible notes payable - related party, net		i 70,392			i 70,392
Short-term convertible notes payable, net		i 1,543,923			i 1,637,812
Convertible notes payable in default		i 341,000			i 32,000
Short-term notes payable, net		i 64,174			i 15,989
Derivative liability		i 803,874			i 1,384,775
Total current liabilities		i 4,721,787			i 4,764,108

Long-term convertible notes payable, net		i 49,029			i -
Long-term convertible notes payable, related party, net		i 26,746			i 14,996
Total non-current liabilities		i 75,775			i 14,996

TOTAL LIABILITIES	$	i 4,797,562		$	i 4,779,104
STOCKHOLDERS' DEFICIT
Series E Convertible Preferred Stock, par value $ i 0.0001. i 40,000 shares authorized, i 40,000 shares outstanding at June 30, 2022 and December 31, 2021, respectively		i 4			i 4
Series F Convertible Preferred Stock, par value $ i 0.00001. i 290,400 shares authorized, i 290,400 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively		i 30			i 30
Common stock, $ i 0.00001 par value. i 6.4 billion shares authorized. i 5,962,823,071 and i 5,866,608,915 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively		i 59,628			i 58,666
Additional paid in capital		i 15,478,574			i 15,337,300
Common stock payable		i 727,759			i 640,584
Accumulated deficit		( i 21,161,620	)		( i 20,742,160	)
Effect of foreign currency exchange		i 116,288			i 71,282
TOTAL STOCKHOLDERS' DEFICIT		( i 4,779,337	)		( i 4,634,294	)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$	i 18,225		$	i 144,810

	Six Months Ended June 30,
	2022			2021

CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$	( i 419,460	)	$	( i 5,965,958	)
Stock-based compensation		i 87,175			i 2,233,425
Depreciation, depletion and amortization		i 7,242			i 7,242
Change in fair value of derivative		( i 597,073	)		i 2,262,283
Amortization of discounts on notes payable		i 351,950			i 591,510
Imputed interest		i 4,729			i 2,830
Bad debt expense		i -			i 150,760

Changes in operating assets and liabilities:
Accounts receivable		i -			( i 760	)
Accounts payable and accrued expenses		i 220,594			i 31,266
Accounts payable - related party		i 113,000			i 112,365
Net cash used in operating activities		( i 231,843	)		( i 575,037	)

CASH FLOWS FROM INVESTING ACTIVITIES
Investment in note receivable		i -			( i 150,000	)
Net cash used in investing activities		i -			( i 150,000	)

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable		i 100,000			i 708,000
Proceeds from convertible notes payable, related party		i -			i 40,000
Payment of expenses by related parties		i -			i 6,000
Proceeds from notes payable		i 50,000			i -
Principal payments on related-party loans		i -			( i 21,348	)
Net cash provided by financing activities		i 150,000			i 732,652

Effect of exchange rate changes on cash and cash equivalents		( i 37,500	)		( i 1,184	)

Net increase/(decrease) in cash		( i 119,343	)		i 6,431
Cash and equivalents - beginning of period		i 119,466			i 114,527
Cash and equivalents - end of period	$	i 123		$	i 120,958

SUPPLEMENTARY INFORMATION
Cash paid for interest	$	i -		$	i -
Cash paid for income taxes	$	i -		$	i -

SUPPLEMENTAL DISCLOSURES OF NON-CASH FINANCING TRANSACTIONS
Discounts on convertible notes	$	i 7,200		$	i 623,573
Conversion of debt and interest to common stock	$	i 88,963		$	i 660,000
Settlement of derivative liability	$	i 45,351		$	i 376,913

Tautachrome Inc. – ‘10-Q’ for 6/30/22

On: Friday, 8/5/22, at 12:40pm ET · For: 6/30/22 · Accession #: 1477932-22-5672 · File #: 0-55721

Previous ‘10-Q’: ‘10-Q’ on 5/17/22 for 3/31/22 · Next & Latest: ‘10-Q’ on 11/21/22 for 9/30/22

Quarterly Report — Form 10-Q

Filing Table of Contents

‘10-Q’ — Quarterly Report

Document Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

PART I - FINANCIAL INFORMATION	3
Item 1 - Consolidated Financial Statements	3
Item 2 - Management’s Discussion And Analysis Of Financial Condition And Results Of Operations	15
Item 3 - Quantitive And Qualitative Disclosures About Market Risk	18
Item 4 - Controls and Procedures	18
PART II - OTHER INFORMATION	19
Item 1 - Legal Proceedings	19
Item 2 - Unregistered Sale of Equity Securities	19
Item 3 - Defaults Upon Senior Securities	19
Item 4 - Mine Safety Disclosures	19
Item 5 - Other Information	19
Item 6 - Exhibits	20
Signatures	21

	1.	KlickZie ARk technology business: The Company has licensed and is developing a new KlickZie augmented reality (“AR”) platform branded ARknet. ARknet enables goods and services providers to establish geolocated augmented reality interfaces, called ARks, allowing consumers to purchase the provider’s products and take advantage of is specials and discounts, using the ARk. A provider’s ARk may be located anywhere in the world, from a store location to anyplace else the provider may desire. The ARknet is a fintech platform connecting consumers to providers in the global $48 trillion household goods market, using augmented reality as the medium of interaction.
	2.	KlickZie’s blockchain cryptocurrency-based ecosystem: The Company has developed its own digital currency (“KLK”), smart contracts using KLKs, and high speed blockchain concepts aimed at supporting fast frictionless transactions within the ARknet as well as incentivizing user download and use of KlickZie products.
	3.	KlickZie Activated Digital Imagery business: The Company is developing downloadable apps based on our patented KlickZie trusted imaging technology and based on our patented trusted image-based social interactions using the pictures and videos that smartphone users create. Trusted imagery and user imagery-based interaction is expected to be widely used within the ARknet.

	·	i 94,614,156 shares converting $ i 83,171 of principal and $ i 5,792 in interest for convertible debt into equity. We recognized no gain or loss on the transactions.
	·	i 1,600,000 shares an enticement for a convertible promissory note. We valued the shares at the grant date fair value and included $ i 3,200 into equity. We accounted for the cost of these shares as a debt discount to be amortized over the life of the loan.

	06/30/22		12/31/21
Loans from related parties	$	i 102,713	$	i 103,640
Convertible notes payable, related party		i 70,392		i 70,392
Short-term convertible notes payable, net		i 1,543,923		i 1,637,812
Convertible notes payable in default		i 341,000		i 32,000
Short-term notes payable, net		i 64,174		i 15,989
Derivative liability		i 803,874		i 1,384,775
Long-term convertible notes payable, net		i 49,029		i -
Long-term convertible notes payable, related party		i 26,746		i 14,996
Totals	$	i 3,001,851	$	i 3,259,604

	·	The stock price of $ i 0.00310 at June 30, 2022 which decreased to $ i 0.00070 by June 30, 2022 and would fluctuate with the Company projected volatility.
	·	i The notes convert with variable conversion prices based on the percentages of the low or average trades or bids over 20 to 25 trading days.
	·	The effective discounts rates estimated throughout the periods range are i 37%.
	·	The Holder would automatically convert the note before maturity if the registration was effective and the company was not in default.
	·	The projected annual volatility for each valuation period was based on the historic volatility of the company are i 140% – i 191% (annualized over the term remaining for each valuation).
	·	i An event of default would occur 0% of the time, increasing 1.00% per month to a maximum of 20%.
	·	i The Holders would redeem the notes (with penalties up to 50% depending on the date and full–partial redemption) based on availability of alternative financing of 0% of the time, increasing 1.00% per month to a maximum of 5%.
	·	The Holder would automatically convert the note at the maximum of 2 times the conversion price or the stock price on the date of valuation.
	·	The Holder would automatically convert the note based on ownership or trading volume limitations.

Balance, December 31, 2021	$	i 1,384,775
Changes due to new issuances		i 61,523
Changes due to extinguishments		( i 45,351	)
Changes due to adjustment to fair value		( i 597,073	)
Balance, June 30, 2022	$	i 803,874

	06/30/22			12/31/21

Net operating loss carry-forward		i 8,667,777			i 8,095,091
Deferred tax asset	$	i 1,820,233		$	i 1,699,969
Valuation allowance		( i 1,820,233	)		( i 1,699,969	)
Net future income taxes	$	i -		$	i -

Exhibit No.		Description of Exhibit
31.1*		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
32.1**		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101.INS*		XBRL Instance Document
101.SCH*		XBRL Taxonomy Extension Schema Document
101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		XBRL Taxonomy Extension Label Linkbase Document
101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document

	Tautachrome, Inc

Date: August 1, 2022	By:	/s/ *Dr. Jon Leonard*
		Dr. Jon Leonard Chief Executive Officer

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	8/5/22
	8/1/22
	7/5/22
For Period end:	6/30/22
	3/24/22	10-K
	12/31/21	10-K
	10/5/21
	3/24/21
	12/31/20	10-K
	3/31/18	10-Q
	9/25/17	8-K
	11/5/15	8-K
	8/8/13
	5/5/13
	12/15/09
	6/5/06
		List all Filings